Jesper Hoeiland
Director · Allarity Therapeutics, Inc.
Individual
- 2026
- May 11, 2026
- 1
Filings (90d)
Other insiders active in the same sector
No other insider has filed at Jesper Hoeiland's companies, so these are insiders reporting open-market trades at other companies in the same sector.
- Mozart Aggregator II LP - $579.20M in MDLN purchases and sales in the last 12 months
- TC Group VII S1, L.L.C. - $554.95M in MDLN purchases and sales in the last 12 months
- BERKSHIRE HATHAWAY INC - $473.67M in DVA purchases and sales in the last 12 months
- RA CAPITAL MANAGEMENT, L.P. - $430.69M in PBLS purchases and sales in the last 12 months
- Fairmount Funds Management LLC - $399.66M in SYRE purchases and sales in the last 12 months
- Paul R. Vigano - $371.84M in AVAH purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Jesper Hoeiland?
Jesper Hoeiland is a corporate insider, tracked as Director of Allarity Therapeutics, Inc. (ALLR). InsiderAlpha holds 1 primary Form 4 filing for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
When did Jesper Hoeiland last file a Form 4?
The only primary Form 4 on record is dated 11 May 2026.
